Regeneron's therapy is part of a class of treatments known as monoclonal antibodies, which are made to act as immune cells that scientists hope can fight infections.
from Health and Science https://ift.tt/3nMBce9
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH
No comments:
Post a Comment